Case Study

The Cardiac Rhythm Center at John Muir Health in the San Francisco Bay area of California performs electrophysiology (EP) procedures on a system that integrates diagnostic and therapeutic devices, workstations, data repositories and reporting functions.

Home March 09, 2009
Home
Feature | Eric Powers, M.D., medical director of The Heart and Vascular Center, MUSC

Door-to-balloon time can be used as a quality measure for hospitals in their level of excellence in caring for patients with acute ST-elevation myocardial infarction (STEMI). It can also be used as a conceptual framework for thinking about quality improvement, differences between outcomes-focused and process-focused quality programs.

Home March 09, 2009
Home
Case Study

The Washington Hospital, an acute care facility serving primarily an elderly patient population, performs approximately 4,300 cardiac and vascular procedures annually. Due to a recent expansion, The Washington Hospital’s Heart and Vascular Center needed to upgrade its equipment and its critical information systems.

Home March 09, 2009
Home
Feature | Dave Fornell

Congenital heart disease contributes to more than 30 percent of infant mortality in the U.S., so time is essential in diagnosing and treating these conditions in newborns. However, most hospitals do not have pediatric cardiac specialists on staff who can diagnose and suggest courses of treatment, which is why telecardiology has bloomed in this field.

Home March 09, 2009
Home
Dave Fornell is the editor of DAIC magazine
Feature

The dividing line between the jobs performed by cardiac surgeons and interventionalists will become increasing blurred in the near future as transcatheter heart valves and PFO occluders replace open-heart surgery. These nonsurgical structural heart treatment techniques were among some of the most exciting trends at TCT 2008, which was highlighted by nearly 40 sessions on these subjects.

Home March 09, 2009
Home
Feature | Nick Obradovich

With the healthcare industry striving for greater efficiency at virtually every level, it shouldn’t be a surprise that hospitals and clinics are increasingly turning to manage patients with implantable cardiac devices remotely, including implantable cardioverter-defibrillators (ICDs), cardiac resynchronization therapy-defibrillators (CRT-Ds) and pacemakers.

Home March 09, 2009
Home
The Cook Evolution lead extraction system.
Feature | Dave Fornell

Management of implanted leads for pacemakers and defibrillators is a growing concern among physicians with more than 2 million Americans relying on a pacemaker or defibrillator to regulate their heart beat and that number growing each year. The lead is the most vulnerable part of an implantable device and the most common component to fail.

Home March 09, 2009
Home
News

March 9, 2009 - The use of dual-source computed tomography (DSCT) may be useful to noninvasively detect in-stent restenosis, especially in stents with a relatively large diameter, according to a study in this week’s issue of the American Journal of Cardiology (pages 812-817).

Home March 09, 2009
Home
News

March 9, 2009 – Merck & Co. Inc. and Schering-Plough Corp. today said their Boards of Directors unanimously approved a merger agreement under which the companies will combine under the name Merck.

Home March 09, 2009
Home
Technology

March 9, 2009 - Ziosoft’s new monthly subscription program for its Ziostation software will allow facilities to utilize Ziosoft's thin-client system immediately without a capital investment. In addition to the monthly subscription fee program, the company will also offer flexible purchasing plans tailored to customers' needs.

Home March 09, 2009
Home
News

March 9, 2009 - The Ministry of Health for the Province of Quebec has awarded ZOLL Medical Corp. a contract valued in excess of $12 million to equip all ambulances in the Canadian province with the ZOLL E Series defibrillator, representing the first time the Province of Quebec will standardize its entire system to one model of defibrillator.

Home March 09, 2009
Home
News

March 9, 2009 - Cytori Therapeutics Inc. completed enrollment in its APOLLO trial to evaluate the safety and feasibility of adipose tissue-derived stem and regenerative cells, processed with the company’s Celution System, in the treatment of severe heart attacks.

Home March 09, 2009
Home
Technology

iNtuition is TeraRecon's new, unified workflow platform, which delivers the best possible solution for advanced image management in an enterprise and an efficient way to manage workflow once the CT data leaves the MDCT scanner.

Home March 09, 2009
Home
Technology

March 9, 2008 - Biomaterials company SyntheMed Inc. has received FDA approval of its pre-market approval (PMA) application for REPEL-CV Adhesion Barrier for use in pediatric cardiac surgery patients.

Home March 09, 2009
Home
News

March 9, 2009 - A study, presented at the 21st European Congress of Radiology, comparing the performance of TeraRecon’s Aquarius iNtuition solution with a competitor’s solution for assessment of Cardiac CT studies, concluded that TeraRecon’s solution increased performance with less operator interaction.

Home March 09, 2009
Home
Subscribe Now